These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 20509340)
1. A study of steroid-induced diabetes mellitus in leprosy. Papang R; John AS; Abraham S; Rao PS Indian J Lepr; 2009; 81(3):125-9. PubMed ID: 20509340 [TBL] [Abstract][Full Text] [Related]
2. Adverse events of standardized regimens of corticosteroids for prophylaxis and treatment of nerve function impairment in leprosy: results from the 'TRIPOD' trials. Richardus JH; Withington SG; Anderson AM; Croft RP; Nicholls PG; Van Brakel WH; Smith WC Lepr Rev; 2003 Dec; 74(4):319-27. PubMed ID: 14750577 [TBL] [Abstract][Full Text] [Related]
3. [Glucocorticoid-induced diabetes mellitus in gastrointestinal diseases]. Kern W; Stange EF; Fehm HL; Klein HH Z Gastroenterol; 1999 Jun; Suppl 1():36-42. PubMed ID: 10444814 [TBL] [Abstract][Full Text] [Related]
4. Reactions and their management. Ganapati R; Pai VV J Indian Med Assoc; 2004 Dec; 102(12):688-90, 692, 694. PubMed ID: 15871353 [TBL] [Abstract][Full Text] [Related]
5. The INFIR Cohort Study: investigating prediction, detection and pathogenesis of neuropathy and reactions in leprosy. Methods and baseline results of a cohort of multibacillary leprosy patients in north India. van Brakel WH; Nicholls PG; Das L; Barkataki P; Suneetha SK; Jadhav RS; Maddali P; Lockwood DN; Wilder-Smith E; Desikan KV Lepr Rev; 2005 Mar; 76(1):14-34. PubMed ID: 15881033 [TBL] [Abstract][Full Text] [Related]
6. The prognostic importance of detecting mild sensory impairment in leprosy: a randomized controlled trial (TRIPOD 2). Van Brakel WH; Anderson AM; Withington SG; Croft RP; Nicholls PG; Richardus JH; Smith WC Lepr Rev; 2003 Dec; 74(4):300-10. PubMed ID: 14750575 [TBL] [Abstract][Full Text] [Related]
7. A case series of steroid-induced diabetes mellitus in Zaria, Nigeria. Babadoko AA; Ijei IP; Bello-Manga H; Hassan A; Manu M Niger J Med; 2014; 23(3):267-70. PubMed ID: 25185386 [TBL] [Abstract][Full Text] [Related]
8. Effect of steroid therapy on parameters of peripheral autonomic dysfunction in leprosy patients with acute neuritis. Wilder-Smith A; Wilder-Smith E Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):20-7. PubMed ID: 9207750 [TBL] [Abstract][Full Text] [Related]
9. Multi-centre, double blind, randomized trial of three steroid regimens in the treatment of type-1 reactions in leprosy. Rao PS; Sugamaran DS; Richard J; Smith WC Lepr Rev; 2006 Mar; 77(1):25-33. PubMed ID: 16715687 [TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid-induced diabetes mellitus: prevalence and risk factors in primary renal diseases. Uzu T; Harada T; Sakaguchi M; Kanasaki M; Isshiki K; Araki S; Sugiomoto T; Koya D; Haneda M; Kashiwagi A; Yamauchi A Nephron Clin Pract; 2007; 105(2):c54-7. PubMed ID: 17135768 [TBL] [Abstract][Full Text] [Related]
11. Steroid-induced diabetes mellitus and related risk factors in patients with neurologic diseases. Iwamoto T; Kagawa Y; Naito Y; Kuzuhara S; Kojima M Pharmacotherapy; 2004 Apr; 24(4):508-14. PubMed ID: 15098806 [TBL] [Abstract][Full Text] [Related]
12. Steroid therapy for paralytic deformities in leprosy. Sugumaran DS Int J Lepr Other Mycobact Dis; 1997 Sep; 65(3):337-44. PubMed ID: 9401486 [TBL] [Abstract][Full Text] [Related]
13. Long term follow-up results of 1 year MDT in MB leprosy patients treated with standard MDT + once a month Minocycline and Ofloxacin. Katoch K; Katoch VM; Natarajan M; Gupta UD; Sharma VD; Singh HB Indian J Lepr; 2008; 80(4):331-44. PubMed ID: 20329382 [TBL] [Abstract][Full Text] [Related]
14. Detection of undiagnosed diabetes and prediabetic states in high-risk emergency department patients. Charfen MA; Ipp E; Kaji AH; Saleh T; Qazi MF; Lewis RJ Acad Emerg Med; 2009 May; 16(5):394-402. PubMed ID: 19302369 [TBL] [Abstract][Full Text] [Related]
15. Experience with the combination of clofazimine (Lamprene) and long-term steroid therapy in the treatment of leprosy. Hogerzeil LM Lepr India; 1976 Oct; 48(4 Suppl):718-21. PubMed ID: 1026809 [TBL] [Abstract][Full Text] [Related]
16. New lesions after MDT in PB and MB leprosy: a report of 28 cases. Kar HK; Sharma P Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355 [TBL] [Abstract][Full Text] [Related]
17. Reaction cases treated at the Regional Leprosy Training and Research Institute, Aska, Orissa: a retrospective analysis. Santaram V; Porichha D Indian J Lepr; 2004; 76(4):310-20. PubMed ID: 16119141 [TBL] [Abstract][Full Text] [Related]
18. Combined 12-month WHO/MDT MB regimen and Mycobacterium w. vaccine in multibacillary leprosy: a follow-up of 136 patients. Kaur I; Dogra S; Kumar B; Radotra BD Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):174-81. PubMed ID: 12483965 [TBL] [Abstract][Full Text] [Related]
19. Long-term steroid treatment and growth: a study in steroid-dependent nephrotic syndrome. Simmonds J; Grundy N; Trompeter R; Tullus K Arch Dis Child; 2010 Feb; 95(2):146-9. PubMed ID: 20172895 [TBL] [Abstract][Full Text] [Related]
20. Thalidomide in leprosy--study of 94 cases. Parikh DA; Ganapati R; Revankar CR Indian J Lepr; 1986; 58(4):560-6. PubMed ID: 3572098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]